麦得发完成B轮融资,两大百亿医药企业已入局

动脉网
Jan 11

珠海麦得发生物科技股份有限公司宣布完成B轮融资,由中国太平创新和广药资本联合投资,金额未披露。加上现有股东丽珠医药,已有两大百亿营收医药企业入局麦得发。此前,麦得发于2021年3月完成天使轮融资,2022年5月完成A轮数千万人民币融资,2023年12月完成数千万元人民币A+轮融资。麦得发定位“医药+PHA”创新企业,第三大股东丽珠医药自其成立之初便深度参与,这或可解释麦得发重点发力医用级PHA和...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10